查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1529630

電池起始材料市場規模、佔有率、趨勢分析報告：按產品、按等級、按最終用途、按地區、細分市場預測，2024-2030 年

Cellular Starting Materials Market Size, Share & Trends Analysis Report By Product (Leukopaks, Cells & Tissues), By Grade (GMP, Research-use), By End U-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

電池起始材料市場成長與趨勢：

根據Grand View Research, Inc.最新報告，預計到2030年，全球電池起始材料市場規模將達到48.4億美元，預計2024年至2030年複合年成長率為22.74%。

癌症、糖尿病和自體免疫疾病等慢性疾病的盛行率不斷上升，投資不斷增加，對細胞和基因療法的需求不斷增加，以及技術創新預計將在預測期內加強細胞原料市場。

細胞起始材料在支持細胞和基因療法的發展中發揮重要作用。這些對於自體和同種異體細胞治療都是必不可少的。隨著細胞治療領域的不斷快速擴展，對高品質人類細胞起始材料的需求不斷增加。基於細胞的療法正在針對多種疾病進行研究，包括癌症、神經退化性疾病和自體免疫疾病，增加了對不同類型起始材料的需求。此外，生物加工技術、細胞培養技術和品管措施的不斷進步正在提高細胞原料製造的效率和擴充性，使公司能夠提高這些材料的生產效率和可擴展性，同時保持產品品質和一致性。因應增加的需求。

COVID-19 大流行對市場產生了重大影響，供應鏈和製造流程中斷，導致供不應求和製造計劃延遲。對於自體細胞療法，患者來源的細胞被用作起始材料，因此大流行延長了患者收集期。然而，這場大流行凸顯了細胞療法的重要性，導致該領域的投資增加，並加速了一些治療方法的監管核准。

然而，與細胞治療相關的嚴格法規對細胞起始材料市場構成了重大挑戰。這些法規增加了細胞和基因治療產品的製造成本以及獲取起始材料的成本。世界各地對於細胞治療的細胞起始材料的收集、加工和使用都有具體的規定。符合 21 CFR 1271.10(a) 中概述的具體標準的細胞治療產品僅作為美國細胞、組織或細胞/組織衍生產品 (HCT/Ps) 根據《公共衛生服務法》第 361 條進行監管。

電池起始材料市場報告亮點

  • 2023年， 隱色將以70.80%的市場佔有率佔據該產品領域的主導地位。
  • 到 2023 年，GMP 將在該等級細分市場中佔據主導地位，按收益計算佔據最大的市場佔有率，預計在預測期內將以 22.78% 的複合年成長率成長最高。
  • 製藥和生物技術公司在最終用途市場佔據主導地位，2023 年所佔佔有率最大，為 51.04%。這是由於在研發方面進行了大量投資，將新的治療方法推向市場，以及使用細胞起始材料作為製造過程中的關鍵組成部分。
  • 從最終用途來看，由於先進研究和製造技術投資的增加，CMO 和 CRO 領域預計將以最快的複合年成長率成長。
  • 由於研發活動投資增加、細胞療法需求增加以及先進的醫療基礎設施等因素，北美地區以 43.49% 的佔有率主導細胞起始材料市場。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章 細胞起始材料市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
  • 電池原物料市場分析工具

第4章 電池原料市場：依產品分類的估算與趨勢分析

  • 細分儀表板
  • 全球電池原料市場分產品波動分析
  • 2018-2030年全球電池原料市場規模及趨勢分析（分產品）
  • 隱色包
  • 細胞和組織

第5章 電池原料市場：依等級估算及趨勢分析

  • 細分儀表板
  • 全球電池原料市場依等級變化分析
  • 2018-2030年全球電池原料市場規模及趨勢分析（依等級）
  • GMP
  • 研究

第6章 電池原料市場：依最終用途分類的估算與趨勢分析

  • 細分儀表板
  • 全球電池原料市場最終用途的波動分析
  • 2018-2030 年全球蜂窩原料市場規模與趨勢分析（依最終用途）
  • 製藥和生物技術公司
  • 首席行銷長和首席研究官
  • 學術研究所

第7章 電池原料市場：區域估算與趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
    • 2018-2030 年北美市場估計與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030 年歐洲市場估計與預測
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030 年亞太市場估計與預測
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 2018-2030 年拉丁美洲市場估計與預測
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 2018-2030 年中東和非洲市場估計和預測
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 公司/競爭對手分類
  • 策略規劃
  • 2023 年企業市場分析
  • 公司簡介/上市公司
    • AllCells
    • Charles River Laboratories
    • BioIVT
    • NMDP BioTherapies
    • CGT GLOBAL
    • Excellos
    • Anthony Nolan
    • STEMCELL Technologies
    • HumanCells Bio
    • AcceGen
Product Code: GVR-4-68040-323-4

Cellular Starting Materials Market Growth & Trends:

The global cellular starting materials market size is anticipated to reach USD 4.84 billion by 2030, growingand is anticipated to expand at a CAGR of 22.74% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders, rising investments, growing demand for cell and gene-based therapies, and technological innovations are expected to enhance the cellular starting materials market over the forecast period.

Cellular starting materials play a crucial role in supporting the development of cell and gene therapies. They are essential for both autologous and allogeneic cell therapies. As the field of cell therapy continues to expand rapidly, the demand for high-quality human cellular starting material is increasingincreases. Cell-based treatments are being investigated for a variety of conditions, including oncology, neurodegenerative disorders, and autoimmune diseases, leading to increased demand for different types of starting materials. Moreover, ongoing advancements in bioprocessing technologies, cell culture techniques, and quality control measures have enhanced the efficiency and scalability of manufacturing cellular starting materials, enabling companies to meet the increasing demand for these materials while maintaining product quality and consistency.

The COVID-19 pandemic had a significant impact onsignificantly impacted the market, with disruptions in supply chains and manufacturing processes leading to shortages and delays in manufacturing timelines. In the case of autologous cell therapies, the pandemic has caused extended patient collection times as patient-derived cells are used as starting material. However, the pandemic also underscored the importance of cell-based therapies and led to increased investments in the sector and accelerated regulatory approvals for some treatments.

However, strict regulations related to cell therapies present a major challenge to the cellular starting materials market. These regulations increase the costs of manufacturing cell and gene therapy products and obtaining the starting material. Various regions around the worldworldwide have established specific regulations governing the collection, processing, and use of cellular starting material for cell therapies. Cellular therapy products meeting specific criteria outlined in 21 CFR 1271.10(a) are regulated solely as Human Cells, Tissues, and Cellular and & Tissue-Based Products (HCT/Ps) under Section 361 of the Public Health Service Act of the U.S.

Cellular Starting Materials Market Report Highlights:

  • Leukopaks dominated the product segment with a market share of 70.80% in 2023, as they are essential cellular starting materials for cell-based therapies.
  • In 2023, GMP dominated the grade segment and held the largest market share in terms of revenue and is expected to grow at the highest CAGR of 22.78% over the forecast period.
  • Pharmaceutical and biotechnology companies dominated the end-use market with the largest share of 51.04% in 2023, driven by their significant investment in research and development to bring novel treatments to market, leveraging cellular starting materials as key components in their manufacturing processes.
  • Based on end use, tThe CMOs & CROs segment is anticipated to grow at the fastest CAGR due to their increasing adoption and investment in advanced research and manufacturing technologies.
  • The North American region dominated the cellular starting materials market with a share of 43.49% owing to factors such as increasing investments in R&D activities, rising demand for cell-based therapies, and advanced healthcare infrastructure.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Grade Segment
    • 1.2.3. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Cellular Starting Materials Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising demand for cell therapies
      • 3.2.1.2. Advancements in research and development for cell-based therapies
      • 3.2.1.3. Technological innovation
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost associated with the production and procurement of raw materials for cell therapies
      • 3.2.2.2. Stringent regulations associated with cell therapies
  • 3.3. Cellular Starting Materials Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Cellular Starting Materials Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Cellular Starting Materials Market Product Movement Analysis
  • 4.3. Global Cellular Starting Materials Market Size & Trend Analysis, by Product, 2018 - 2030 (USD Million)
  • 4.4. Leukopaks
    • 4.4.1. Leukopaks market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.5. Cells & Tissues
    • 4.5.1. Cells & tissues market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. Cellular Starting Materials Market: Grade Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Cellular Starting Materials Market Grade Movement Analysis
  • 5.3. Global Cellular Starting Materials Market Size & Trend Analysis, by Grade, 2018 - 2030 (USD Million)
  • 5.4. GMP
    • 5.4.1. GMP market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.5. Research-use
    • 5.5.1. Research-use market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. Cellular Starting Materials Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Cellular Starting Materials Market End Use Movement Analysis
  • 6.3. Global Cellular Starting Materials Market Size & Trend Analysis, by End Use, 2018 - 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5. CMOs & CROs
    • 6.5.1. CMOs & CROs market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.6. Academic & Research Institutes
    • 6.6.1. Academic & research institutes market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Cellular Starting Materials Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 - 2030 (2018 - 2030)
  • 7.4. North America
    • 7.4.1. North America market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. Regulatory framework
      • 7.4.2.4. Target disease prevalence
      • 7.4.2.5. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Regulatory framework
      • 7.4.3.4. Target disease prevalence
      • 7.4.3.5. Canada market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Competitive scenario
      • 7.4.4.3. Regulatory framework
      • 7.4.4.4. Target disease prevalence
      • 7.4.4.5. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. Target disease prevalence
      • 7.5.2.5. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.3. UK
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. Target disease prevalence
      • 7.5.3.5. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. Regulatory framework
      • 7.5.4.4. Target disease prevalence
      • 7.5.4.5. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Regulatory framework
      • 7.5.5.4. Target disease prevalence
      • 7.5.5.5. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Regulatory framework
      • 7.5.6.4. Target disease prevalence
      • 7.5.6.5. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Regulatory framework
      • 7.5.7.4. Target disease prevalence
      • 7.5.7.5. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Competitive scenario
      • 7.5.8.3. Regulatory framework
      • 7.5.8.4. Target disease prevalence
      • 7.5.8.5. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key country dynamics
      • 7.5.9.2. Competitive scenario
      • 7.5.9.3. Regulatory framework
      • 7.5.9.4. Target disease prevalence
      • 7.5.9.5. Norway market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Target disease prevalence
      • 7.6.2.5. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.3. Japan
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Target disease prevalence
      • 7.6.3.5. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework
      • 7.6.4.4. Target disease prevalence
      • 7.6.4.5. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory framework
      • 7.6.5.4. Target disease prevalence
      • 7.6.5.5. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory framework
      • 7.6.6.4. Target disease prevalence
      • 7.6.6.5. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Target disease prevalence
      • 7.6.7.4. Regulatory framework
      • 7.6.7.5. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Target disease prevalence
      • 7.7.2.5. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Target disease prevalence
      • 7.7.3.5. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. Target disease prevalence
      • 7.8.2.5. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Regulatory framework
      • 7.8.3.4. Target disease prevalence
      • 7.8.3.5. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive scenario
      • 7.8.4.3. Regulatory framework
      • 7.8.4.4. Target disease prevalence
      • 7.8.4.5. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Competitive scenario
      • 7.8.5.3. Regulatory framework
      • 7.8.5.4. Target disease prevalence
      • 7.8.5.5. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. AllCells
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Charles River Laboratories
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. BioIVT
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. NMDP BioTherapies
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. CGT GLOBAL
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Excellos
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Anthony Nolan
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. STEMCELL Technologies
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. HumanCells Bio
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. AcceGen
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global cellular starting materials market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 5 Global cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 6 North America cellular starting materials market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 9 North America cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 11 U.S. cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 12 U.S. cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 14 Canada cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 15 Canada cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 17 Mexico cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 18 Mexico cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe cellular starting materials market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 21 Europe cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 22 Europe cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Germany cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 24 Germany cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 25 Germany cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 26 UK cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 27 UK cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 28 UK cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 30 France cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 31 France cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 33 Italy cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 34 Italy cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 36 Spain cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 37 Spain cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Denmark cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 39 Denmark cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 40 Denmark cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 42 Sweden cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 43 Sweden cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Norway cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 45 Norway cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 46 Norway cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific cellular starting materials market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 51 China cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 52 China cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 53 China cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Japan cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 55 Japan cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 56 Japan cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 58 India cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 59 India cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 60 South Korea cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 61 South Korea cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 62 South Korea cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Australia cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 64 Australia cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 65 Australia cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 67 Thailand cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 68 Thailand cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America cellular starting materials market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 71 Latin America cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 72 Latin America cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 74 Brazil cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 75 Brazil cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 77 Argentina cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 78 Argentina cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 79 MEA cellular starting materials market, by country, 2018 - 2030 (USD Million)
  • Table 80 MEA cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 81 MEA cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 82 MEA cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 83 South Africa cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 84 South Africa cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 85 South Africa cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 89 UAE cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 90 UAE cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 91 UAE cellular starting materials market, by end use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait cellular starting materials market, by product, 2018 - 2030 (USD Million)
  • Table 93 Kuwait cellular starting materials market, by grade, 2018 - 2030 (USD Million)
  • Table 94 Kuwait cellular starting materials market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Cellular Starting Materials market: Market outlook
  • Fig. 5 Cellular Starting Materials market: Segment outlook
  • Fig. 6 Cellular Starting Materials market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Cellular starting materials market driver impact
  • Fig. 9 Cellular starting materials market restraint impact
  • Fig. 10 Cellular starting materials market: Product outlook and key takeaways
  • Fig. 11 Cellular starting materials market: Product movement analysis
  • Fig. 12 Leukopaks market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Cells & tissues market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Cellular starting materials market: Grade outlook and key takeaways
  • Fig. 15 Cellular starting materials market: Grade movement analysis
  • Fig. 16 GMP market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Research-use market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Cellular starting materials market: End use outlook and key takeaways
  • Fig. 19 Cellular starting materials market: End use movement analysis
  • Fig. 20 Pharmaceutical & biotechnology companies market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 21 CMOs & CROs market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 22 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Global cellular starting materials market: Regional outlook and key takeaways
  • Fig. 24 Global cellular starting materials market: Regional movement analysis
  • Fig. 25 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Key country dynamics
  • Fig. 27 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Target Disease Prevalence
  • Fig. 29 Key country dynamics
  • Fig. 30 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Target Disease Prevalence
  • Fig. 32 Key country dynamics
  • Fig. 33 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Target Disease Prevalence
  • Fig. 35 Key country dynamics
  • Fig. 36 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Target Disease Prevalence
  • Fig. 40 Key country dynamics
  • Fig. 41 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Target Disease Prevalence
  • Fig. 43 Key country dynamics
  • Fig. 44 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Target Disease Prevalence
  • Fig. 46 Key country dynamics
  • Fig. 47 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Target Disease Prevalence
  • Fig. 49 Key country dynamics
  • Fig. 50 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Target Disease Prevalence
  • Fig. 52 Key country dynamics
  • Fig. 53 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Target Disease Prevalence
  • Fig. 55 Key country dynamics
  • Fig. 56 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Target Disease Prevalence
  • Fig. 58 Key country dynamics
  • Fig. 59 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Target Disease Prevalence
  • Fig. 61 Key country dynamics
  • Fig. 62 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Target Disease Prevalence
  • Fig. 66 Key country dynamics
  • Fig. 67 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Target Disease Prevalence
  • Fig. 69 Key country dynamics
  • Fig. 70 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Target Disease Prevalence
  • Fig. 72 Key country dynamics
  • Fig. 73 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Target Disease Prevalence
  • Fig. 75 Key country dynamics
  • Fig. 76 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Target Disease Prevalence
  • Fig. 78 Key country dynamics
  • Fig. 79 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Target Disease Prevalence
  • Fig. 81 Key country dynamics
  • Fig. 82 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Target Disease Prevalence
  • Fig. 86 Key country dynamics
  • Fig. 87 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Target Disease Prevalence
  • Fig. 89 Key country dynamics
  • Fig. 90 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Target Disease Prevalence
  • Fig. 94 Key country dynamics
  • Fig. 95 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Target Disease Prevalence
  • Fig. 97 Key country dynamics
  • Fig. 98 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Target Disease Prevalence
  • Fig. 100 Key country dynamics
  • Fig. 101 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 102 Target Disease Prevalence
  • Fig. 103 Key country dynamics